Exome Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
208,970
-253,831
| -55% | -$419K | 0.26% | 45 |
|
|
2025
Q1 | $731K | Buy |
462,801
+109,367
| +31% | +$173K | 0.65% | 43 |
|
|
2024
Q4 | $1.18M | Hold |
353,434
| – | – | 0.89% | 42 |
|
|
2024
Q3 | $664K | Hold |
353,434
| – | – | 0.45% | 52 |
|
|
2024
Q2 | $696K | Sell |
353,434
-62,000
| -15% | -$122K | 0.62% | 43 |
|
|
2024
Q1 | $1.28M | Buy |
415,434
+297,334
| +252% | +$913K | 1.09% | 42 |
|
|
2023
Q4 | $275K | Buy |
+118,100
| New | +$275K | 0.27% | 50 |
|